Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"immune checkpoint inhibitors"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Personeni%2C+Nicola%22&type=Person&filter%5B%5D=topic_facet%3A%22immune+checkpoint+inhibitors%22
/vufind/Search/Results?lookfor=%22Personeni%2C+Nicola%22&type=Person&filter%5B%5D=topic_facet%3A%22immune+checkpoint+inhibitors%22
Search /vufind/Search2/Results?lookfor=%22Personeni%2C+Nicola%22&type=Person&filter%5B%5D=topic_facet%3A%22immune+checkpoint+inhibitors%22
PubPharm (8)
1
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment
enthalten in:
Journal of personalized medicine
| 2022
von
Personeni, N.
|
Pressiani, T.
|
Zanuso, V.
| +10
Wird geladen...
2
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma : shedding light on the preclinical rationale and clinical trials
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Cammarota, A.
|
Zanuso, V.
|
D'Alessio, A.
| +3
Wird geladen...
3
The dual checkpoint blockade in unresectable hepatocellular carcinoma : opportunities emerging in clinical trials
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Cammarota, A.
|
Zanuso, V.
|
D'Alessio, A.
| +4
Wird geladen...
4
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Cammarota, A.
|
Zanuso, V.
|
D’Alessio, A.
| +3
Wird geladen...
5
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Cammarota, A.
|
Zanuso, V.
|
D’Alessio, A.
| +4
Wird geladen...
6
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
enthalten in:
Cancers
| 2021
von
Personeni, N.
|
Pressiani, T.
|
D'Alessio, A.
| +13
Wird geladen...
7
Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma
enthalten in:
Expert review of anticancer therapy
| 2021
von
D'Alessio, A.
|
Cammarota, A.
|
Zanuso, V.
| +3
Wird geladen...
8
Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib
enthalten in:
Future oncology (London, England)
| 2019
von
Personeni, N.
|
Pressiani, T.
|
Rimassa, L.
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: immune checkpoint inhibitors
Medienart
8
Aufsätze
8
E-Artikel
8
E-Ressourcen
Zeitschriftentitel
4
Expert opinion on investigational drugs
1
Cancers
1
Expert review of anticancer therapy
1
Future oncology (London, England)
1
Journal of personalized medicine
Alle anzeigen ...
weniger ...
Thema
immune checkpoint inhibitors
6
Journal Article
5
HCC
5
immunotherapy
3
Angiogenesis
3
atezolizumab
3
cabozantinib
3
hepatocellular carcinoma
3
systemic therapy
2
1C39JW444G
2
52CMI0WC3Y
2
Anilides
2
CTLA-4
2
MKI
2
PD-1
2
PD-L1
2
Pyridines
2
TKI
2
durvalumab
2
ipilimumab
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2020-
1
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
Haven't found what you're looking for?
Wird geladen...